Thermo Fisher Scientific (TMO) was Reiterated by Mizuho to “Buy” according to the research note released today. The brokerage firm has raised the Price Target to $ 163 from a previous price target of $160 . Mizuho advised their investors in a research report released on May 3, 2016.
Many Wall Street Analysts have commented on Thermo Fisher Scientific. Thermo Fisher Scientific was Downgraded by Jefferies to ” Hold” on Apr 29, 2016. Company shares were Reiterated by Mizuho on Apr 4, 2016 to “Buy”, Firm has raised the Price Target to $ 160 from a previous price target of $150 .Company shares were Reiterated by Topeka Capital Markets on Mar 2, 2016 to “Buy”, Firm has raised the Price Target to $ 155 from a previous price target of $145 .
On the company’s financial health, Thermo Fisher Scientific reported $1.80 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $1.74. The company had revenue of $4294.80 million for the quarter, compared to analysts expectations of $4113.28 million. The company’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.63 EPS.
Thermo Fisher Scientific opened for trading at $145.01 and hit $146.7699 on the upside on Monday, eventually ending the session at $146.5, with a gain of 1.56% or 2.25 points. The heightened volatility saw the trading volume jump to 15,37,092 shares. Company has a market cap of $58,052 M.
In a different news, on Apr 27, 2016, Daniel P Shine (Senior Vice President) sold 6,013 shares at $146.00 per share price. According to the SEC, on Apr 7, 2016, Seth H Hoogasian (Sr. VP, Gen. Counsel & Sec.) sold 10,000 shares at $142.05 per share price. On Apr 6, 2016, Patrick M Durbin (Senior Vice President) sold 16,250 shares at $142.18 per share price, according to the Form-4 filing with the securities and exchange commission.
Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.